Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to ... FDA approval for Xarelto in the new indication is based on data from the phase 3 MAGELLAN trial, and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback